Found: 15
Select item for more details and to access through your institution.
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2023, v. 159, n. 6, p. 613, doi. 10.1001/jamadermatol.2023.0846
- By:
- Publication type:
- Article
Diffuse Papular Eruption.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 4, p. 443, doi. 10.1001/jamadermatol.2014.3653
- By:
- Publication type:
- Article
Bullous pemphigoid presenting as generalized pruritus: observations in six patients.
- Published in:
- International Journal of Dermatology, 1998, v. 37, n. 7, p. 508
- By:
- Publication type:
- Article
Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 2, p. 305, doi. 10.1007/s40257-022-00739-3
- By:
- Publication type:
- Article
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 4, p. 392, doi. 10.1093/bjd/ljad182
- By:
- Publication type:
- Article
A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail*.
- Published in:
- British Journal of Dermatology, 2021, v. 184, n. 2, p. 270, doi. 10.1111/bjd.19224
- By:
- Publication type:
- Article
Significant improvement of vitiligo with oral tofacitinib treatment.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 6, p. e358, doi. 10.1111/ijd.16323
- By:
- Publication type:
- Article
Caseating granulomas manifesting as aseptic abscesses in the setting of ulcerative colitis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Kasabach- Merritt phenomenon in an adult man with a tufted angioma and cirrhosis responding to radiation, bevacizumab, and prednisone.
- Published in:
- International Journal of Dermatology, 2014, v. 53, n. 9, p. 1165, doi. 10.1111/ijd.12319
- By:
- Publication type:
- Article
Systemic lupus erythematosus with dystrophic calcifications.
- Published in:
- International Journal of Dermatology, 2014, v. 53, n. 1, p. e74, doi. 10.1111/j.1365-4632.2012.05508.x
- By:
- Publication type:
- Article
Toxic epidermal necrolysis in the setting of systemic lupus erythematosus.
- Published in:
- International Journal of Dermatology, 2011, v. 50, n. 10, p. 1270, doi. 10.1111/j.1365-4632.2010.04824.x
- By:
- Publication type:
- Article
Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience.
- Published in:
- International Journal of Dermatology, 2007, v. 46, n. 9, p. 910, doi. 10.1111/j.1365-4632.2007.03214.x
- By:
- Publication type:
- Article
Efficacy of Fixed-combination Calcipotriene 0.005% and Betamethasone Dipropionate 0.064% Foam for Scalp Plaque Psoriasis: Additional Analysis of a Phase II, Randomized Clinical Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Fixed Combination Aerosol Foam Calcipotriene 0.005% (Cal) Plus Betamethasone Dipropionate 0.064% (BD) is More Efficacious than Cal or BD Aerosol Foam Alone for Psoriasis Vulgaris: A Randomized, Double-blind, Multicenter, Three-arm, Phase 2 Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in Psoriasis.
- Published in:
- Advances in Therapy, 2020, v. 37, n. 11, p. 4730, doi. 10.1007/s12325-020-01497-6
- By:
- Publication type:
- Article